Farallon Capital Management’s Tango Therapeutics TNGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$190M Sell
9,097,411
-3,964,000
-30% -$55.2M 1.08% 32
2025
Q4
$116M Buy
13,061,411
+2,304,411
+21% +$19.9M 0.52% 44
2025
Q3
$90.4M Buy
10,757,000
+1,600,000
+17% +$10.8M 0.37% 46
2025
Q2
$46.9M Buy
9,157,000
+4,546,070
+99% +$11.2M 0.2% 56
2025
Q1
$6.32M Buy
4,610,930
+610,930
+15% +$1.5M 0.03% 78
2024
Q4
$12.4M Buy
+4,000,000
New +$18.6M 0.05% 79
2023
Q1
Sell
-270,000
Closed -$1.96M 203
2022
Q4
$1.96M Sell
270,000
-30,000
-10% -$211K 0.01% 167
2022
Q3
$1.09M Hold
300,000
0.01% 214
2022
Q2
$1.36M Hold
300,000
0.01% 212
2022
Q1
$2.27M Hold
300,000
0.01% 212
2021
Q4
$3.28M Hold
300,000
0.02% 199
2021
Q3
$3.88M Hold
300,000
0.02% 201
2021
Q2
$3.41M Buy
+300,000
New +$3.37M 0.01% 197

Other funds holding TNGX